Circulating Tumour DNA and Its Prognostic Role in Management of Muscle Invasive Bladder Cancer: A Narrative Review of the Literature

Current management of non-metastatic muscle invasive bladder cancer (MIBC) includes radical cystectomy and cisplatin-based neoadjuvant chemotherapy (NAC), offers a 5-year survival rate of approximately 50% and is associated with significant toxicities. A growing body of evidence supports the role of...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Konstantinos Kapriniotis, Lazaros Tzelves, Lazaros Lazarou, Maria Mitsogianni, Iraklis Mitsogiannis
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	circulating tumour deoxyribonucleic acid (DNA) ctDNA liquid biopsies bladder cancer muscle invasive bladder cancer (MIBC)
Online Access:	https://www.mdpi.com/2227-9059/12/4/921